Henderson, NV - January 16, 2026 - PRESSADVANTAGE - Las Vegas Eye Institute announces the integration of Ray-Traced ...
LONG BEACH, CA - January 16, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource to help ...
The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.
ST. LOUIS, MO - January 23, 2026 - PRESSADVANTAGE - Brinton Vision today announced the release of its new article, ...
Flavored nicotine pouches called Zyn could soon be legally advertised as a lower-risk option for adults who smoke, as federal ...
OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...
Beware of products claiming to cure cancer on websites or social media platforms, such as Facebook and Instagram. According ...
AI-powered medical wearables and software are flourishing following the FDA’s new hands-off regulatory guidance.
The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...
Americans who smoke may soon be hearing a lot more about Zyn. That's the flavored nicotine pouch that's generated billions in ...